BETHESDA, Md., Feb. 14, 2014 /PRNewswire/ -- Marriott International, Inc. (NASDAQ: MAR) today announced that its board of directors declared a quarterly cash dividend of seventeen cents ($0.17) per share of common stock. The dividend is payable on March 28, 2014 to shareholders of record on February 28, 2014.
(Logo: http://photos.prnewswire.com/prnh/20130531/PH23900LOGO) ;
Marriott also announced that its board has increased the authorization to repurchase the Company's Class A common stock by an additional 25 million shares, for a total of approximately 34.4 million shares currently authorized for repurchase. Shares may be purchased in the open market or in privately negotiated transactions.
In 2013, the company repurchased 20 million shares for $829 million, including 4.4 million shares for $200 million in the fourth quarter. Combined with cash dividends of $196 million paid in 2013, the company returned over $1 billion in cash to shareholders. To date in 2014, Marriott has repurchased nearly 4.9 million shares for approximately $238 million.
Recent MAR News
- MARRIOTT INTERNATIONAL REPORTS FIRST QUARTER 2024 RESULTS • PR Newswire (US) • 05/01/2024 11:00:00 AM
- Westin Hotels & Resorts Bolsters its 'Best in Bed' Reputation with the Global Debut of the Next Generation Heavenly® Bed • PR Newswire (US) • 04/30/2024 02:00:00 PM
- Marriott International Celebrates Milestone on Journey Towards Net-Zero • PR Newswire (US) • 04/22/2024 11:00:00 AM
- Fairfield by Marriott Brings the Beauty of Simplicity to Copenhagen for its European Debut • PR Newswire (US) • 04/08/2024 02:00:00 PM
- MARRIOTT INTERNATIONAL ANNOUNCES RELEASE DATE FOR FIRST QUARTER 2024 EARNINGS • PR Newswire (US) • 04/02/2024 08:30:00 PM
- THE RITZ-CARLTON, SOUTH BEACH AND WOMEN'S POWER SERIES ANNOUNCE SECOND ANNUAL WOMEN'S POWER BREAKFAST IN CELEBRATION OF INTERNATIONAL WOMEN'S DAY • PR Newswire (US) • 03/06/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 12:22:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 04:38:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 10:00:05 PM
- Marriott International Announces Robust Growth Across the Caribbean and Latin America in 2023 • PR Newswire (US) • 02/26/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:12:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 07:13:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 02:14:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 02:14:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 02:14:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:09:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 05:53:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/21/2024 09:58:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 05:17:29 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 02/20/2024 10:25:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:22:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:22:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:21:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:21:43 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM